The only thing worse for the destruction of shareholder value in an established pharma other than Elan is what Phillip Frost did to Ivax Pharma many years ago.Please clarify. Did you think IVAX sold out too cheaply to Teva? I think he has resurfaced in some biotech recently.You’re thinking of OPK.